Other
Changes in unrecognized tax benefits
Vertex Pharmaceuticals Changes in unrecognized tax benefits decreased by 87.6% to 1.4% in Q4 2025 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementIncome Statement
SectionOther
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ4 2023
Last reportedQ4 2025Feb 13, 2026
How to read this metric
An increase suggests higher tax uncertainty or aggressive tax planning, while a decrease indicates resolution of past tax issues.
Detailed definition
Represents the net change in the reserve for uncertain tax positions during the reporting period. This reflects the comp...
Peer comparison
Commonly reported as 'Changes in Unrecognized Tax Benefits' in the tax footnote of most public companies.
Metric ID:
other_effective_income_tax_rate_reconciliation_tax_conti_ef495cHistorical Data
3 periods
| Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|
| Value | 3.4% | 11.3% | 1.4% |
| QoQ Change | — | +232.4% | -87.6% |
| YoY Change | — | +232.4% | -87.6% |
Range1.4% – 11.3%
Avg YoY Growth+72.4%
Median YoY Growth+72.4%
Changes in unrecognized tax benefits at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's changes in unrecognized tax benefits?
- Vertex Pharmaceuticals (VRTX) reported changes in unrecognized tax benefits of 1.4% in Q4 2025.
- What does changes in unrecognized tax benefits mean?
- The net change in the company's reserve for potential tax disputes.